HCM
NUTX

Highbridge Capital Management’s Nutex Health NUTX Stock Holding History

Highbridge Capital Management’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-224,082
Closed -$3.22M – 340
2024
Q1 		$3.22M Buy
+224,082
New +$4.51M 0.12% 89

Other funds holding NUTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OPOWM
One Plus One Wealth Management Jupiter, Florida $232M AUM 28.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SWM
Scissortail Wealth Management Tulsa, Oklahoma $498M AUM 20.41% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Highbridge Capital Management's NUTX Position: Q2 2024 in Review

Highbridge Capital Management sold out of Nutex Health (NUTX) in Q2 2024, closing a stake of 224,082 shares — an estimated $3.22M sold.

Highbridge Capital Management first reported a position in NUTX in Q1 2024 and held it in 1 quarter. The position peaked at $3.22M in Q1 2024. 26 funds tracked by Wall St. Rank hold NUTX as of Q2 2024.

  • Highbridge Capital Management reported no remaining Nutex Health position as of Q2 2024 after selling out during the quarter.
  • Highbridge Capital Management sold 224,082 Nutex Health shares in Q2 2024, an estimated $3.22M.
  • Highbridge Capital Management first reported a position in Nutex Health in Q1 2024 and held it in 1 quarter.
  • Highbridge Capital Management's Nutex Health position peaked at $3.22M in Q1 2024.
  • 26 funds tracked by Wall St. Rank held Nutex Health as of Q2 2024.

Based on Highbridge Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.